Alnylam Pharmaceuticals EDI

Our EDI compliance service for Alnylam Pharmaceuticals allows you to conduct electronic transactions efficiently. This comprehensive service covers certification, testing, training, support, and security monitoring. Cogential IT ensures swift Alnylam Pharmaceuticals EDI compliance with our optimized processes.

Utilizing our cloud-based EDI solution simplifies your connection with Alnylam Pharmaceuticals. Opt for us for a smooth EDI compliance experience.

Easily connect to all your Trading Partners with a compliant EDI Solution.

Alnylam Pharmaceuticals supports following Transaction Sets

Transaction sets are identified by a numeric identifier and a name.

  • 204 - Motor Carrier Load Tender
  • 990 - Response to a Load Tender
  • 214 - Transportation Carrier Shipment Status Message
  • 210 - Motor Carrier Freight Details and Invoice
  • 850 - Purchase Order
  • 855 - Purchase Order Acknowledgment
  • 856 - Ship Notice/Manifest
  • 810 - Invoice
  • 820 - Payment Order/Remittance Advice
  • 875 - Grocery Products Purchase Order
  • 880 - Grocery Products Invoice
  • 997 - Functional Acknowledgment
  • Packing SlipsGS1-128 (or UCC-128) Bar Code Shipping Labels

 

Seamlessly Connect with Alnylam Pharmaceuticals through Cogential IT's EDI Integration Services

Cogential IT offers robust EDI integration services tailored specifically for Alnylam Pharmaceuticals. With our pre-built connectors to leading ERP, TMS, and WMS systems, you can effortlessly link your back-office systems to Alnylam Pharmaceuticals.

Our comprehensive, end-to-end B2B integration solutions streamline your operations, allowing you to efficiently manage your orders, inventory, and shipments. Leveraging our expertise ensures that your business processes are optimized, reducing manual errors and improving overall efficiency.

 

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a pioneering biopharmaceutical company that leverages RNA interference (RNAi) technology to develop innovative therapies. The company's mission is to transform the lives of patients through the discovery, development, and commercialization of novel treatments for rare and serious diseases.

Core Focus Areas

  • RNAi Therapeutics: Alnylam specializes in RNAi therapeutics, a groundbreaking approach that targets the root cause of diseases by silencing specific genes.
  • Clinical Development: The company has a robust pipeline of investigational medicines in various stages of clinical development.
  • Commercialization: Alnylam is committed to bringing its innovative treatments to market, ensuring they reach patients in need.

Therapeutic Areas

  • Genetic Medicines: Treatments for rare genetic disorders.
  • Cardio-Metabolic Diseases: Innovations targeting cardiovascular and metabolic conditions.
  • Hepatic Infectious Diseases: Solutions aimed at liver-related infectious diseases.
  • CNS & Ocular Diseases: Research in treatments for central nervous system and eye disorders.

Industries Served

  • Healthcare: Collaborating with healthcare professionals to provide cutting-edge treatments.
  • Pharmaceuticals: Partnering with pharmaceutical companies for research and development.
  • Biotechnology: Engaging with the biotech community to advance RNAi technology.

icon-75


Simplified EDI

We have expert EDI specialists who make EDI simple, easier and hassle free.
icon-74


Dedicated Solutions

We extend and integrate EDI expertise that is specific to your business needs and objectives.
icon-73


Industry Oriented

Our specific EDI solutions are tailor-made with any industry that you decide to do business with.
icon-76


Reliable Support

We provide 24/7 dedicated support to ensure delivery of great EDI solutions.

Our Trading Partners

At Cogential IT, we are committed to delivering the finest B2B EDI solutions, customized to meet your unique business requirements.
Looking for an EDI or Integration solution? Our experts are here to help you. Book a free demo with us!
Your Name
Your Email
Your Message
  +     =